Countries South Korea
SK Biopharmaceuticals and ProEn Therapeutics to Develop Two Radiopharmaceutical Candidates by 2027 Using ArtBody™ Platform
SK Biopharmaceuticals, ProEn Therapeutics aim to advance up to 2 preclinical radiopharmaceutical candidates by 2027, via ArtBody™, a bivalent binder ...
December 17, 2024 | News
James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
LOTTE BIOLOGICS is pleased to announce that James Park will assume the role of Chief Executive Officer, effective December 11, 2024. Mr. Park brings with ...
December 16, 2024 | News
CHMP Endorses Celltrion’s Biosimilars Eydenzelt Stoboclo Osenvelt and Avtozma for Expanded Access to Biologic Treatments
The Committee for Medicinal Products for Human Use (CHMP) adopts positive opinions for Celltrion’s three biosimilar candidates – Eydenz...
December 16, 2024 | News
HiRO Partners with South Korea’s CHA Bundang Medical Center to Advance Global Clinical Trials
Harvest Integrated Research Organization (HiRO), a boutique global clinical research organization (CRO) providing cross-border clinical trial sol...
December 16, 2024 | News
GNT Pharma Announces Promising Nelonemdaz Results, Initiates Global Phase 3 Stroke Trials
** IND submitted to the FDA showing significantly improved patient condition when administered within 70 minutes of arrival at the Emergency Room ** *Mult...
December 12, 2024 | News
SNUBH, CurePSP, and GemVax Unite to Establish Korea’s First International PSP Research and Treatment Center
MOU Signed Among SNUBH-CurePSP-GemVax for the Establishment of International PSP Research and Treatment Center Tackling Global Challenges in an Aging Er...
December 10, 2024 | News
Samsung Biologics Hosts Second Supplier ESG Day, Rallying Global Partners for Sustainable Value Chains
Samsung Biologics , a global contract development and manufacturing organization (CDMO), hosted its second Supplier ESG Day to share insights on sustainabl...
December 03, 2024 | News
Lunit Partners with Mexico's Salud Digna to Advance AI-Driven Cancer Diagnostics Across Latin America
Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced a strategic partnership with&nbs...
November 28, 2024 | News
South Korea’s Newbase Launches ‘Medicrew,’ Transforming VR-Based Medical Education Globally
Newbase, a leader in metaverse-based medical education platforms, announced on the 28th the launch of its new product, 'Medicrew', a platform designed to p...
November 28, 2024 | News
South Korea’s S.BIOMEDICS Announces Promising Phase 1/2a Data for TED-A9 Cell Therapy in Parkinson’s Disease
-S.BIOMEDICS revealed promising one-year post-transplant data from their Phase 1/2a clinical trial of the TED-A9 cell therapy for Parkinson's disease....
November 27, 2024 | News
HanAll Biopharma, Daewoong Pharmaceutical, and NurrOn Complete Phase 1 Study of HL192 (ATH-399A) for Parkinson’s Disease
HL192 (ATH-399A) was well tolerated with no major safety issues in any of the 76 participants. No serious treatment related adverse events were reported...
November 26, 2024 | News
GC Biopharma and Novel Pharma Dose First US Patient in Pioneering Clinical Trial for Sanfilippo Syndrome Type A
GC Biopharma and Novel Pharma announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new d...
November 26, 2024 | News
Hanmi Showcases Promising Progress in BH3120 Immunotherapy at SITC 2024
Hanmi unveils tiral in progress poster on BH3120 at the Society for Immunotherapy of Cancer (SITC) in the U.S.Phase 1 trial is progressing smoothly, with n...
November 25, 2024 | News
Mongolian Health Officials Tour SD Biosensor Facilities in Korea to Strengthen Infectious Disease Collaboration
A team of officials from the National Center for Communicable Diseases, Mongolia (NCCD), had a tour around the Cheongju and Jeungpyeong Factori...
November 21, 2024 | News
Most Read
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
